Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".

Abstract

BACKGROUND AND PURPOSE The primary purpose of the trial was to assess rate of tumour response to a hypofractionated course of radiotherapy in patients with incurable squamous cell carcinoma of the head and neck (HNSCC). Secondary objectives included radiation toxicity, symptom control, quality of life (QoL) and progression-free and overall survival… (More)

Topics

Cite this paper

@article{Porceddu2007HypofractionatedRF, title={Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".}, author={Sandro V. Porceddu and Brenda Rosser and Bryan H. Burmeister and Mark S. Jones and Brigid E Hickey and Kacy Baumann and Kumar Gogna and Andrew P. Pullar and Michael Poulsen and Tanya R Holt}, journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology}, year={2007}, volume={85 3}, pages={456-62} }